ECOG-ACRIN Cancer Research Group

ECOG-ACRIN Cancer Research Group

ECOG-ACRIN EA6141 Protocol Training [1.0 CEUs]

The EA Clinical Education Team and the EA6141 Study Chair, Dr. F Stephen Hodi, created this Investigator and Site Training on Ipilimumab Immune Related Adverse Events: Summary and Recommended Management. All enrolling Investigators must complete the training prior to their first patient enrollment. Click the blue arrow at the bottom right-hand side of your screen to continue.


EA Clinical Education and Awareness Team
EAClinEd@ecog-acrin.org

Modules in the Course:
ECOG-ACRIN EA6141 Protocol Training [1.0 CEUs]